Inmunología, Oftalmología y ORL
Departamento
![Foto de Inmunología, Oftalmología y ORL](/img/uploaded/7383705E4165CCC3E1D5745D79764C47.png)
![Foto de Hospital General Universitario de Valencia](/img/noimage_org.png)
Hospital General Universitario de Valencia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario de Valencia (9)
2023
-
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
Seminars in Arthritis and Rheumatism, Vol. 58
-
SER recommendations for the treatment of uveitis
Reumatologia Clinica, Vol. 19, Núm. 9, pp. 465-477
2021
-
Long-term Follow-up and optimization of infliximab in refractory uveitis due to Behçet Disease: National study of 103 white patients
Journal of Rheumatology, Vol. 48, Núm. 5, pp. 741-750
2020
-
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515
2019
-
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
American Journal of Ophthalmology, Vol. 200, pp. 85-94
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2018
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
2017
-
Development of an activity disease score in patients with uveitis (UVEDAI)
Rheumatology International, Vol. 37, Núm. 4, pp. 647-656
2013
-
Taller de Autoinmunidad 2013 de la Sociedad Española de Inmunología. Anticuerpos anticitoplasma de neutrófilo (ANCA)
Inmunologia, Vol. 32, Núm. 4, pp. 148-156